JP MORGAN/CALL/BECTON DICKINSON AND CO./280/0.1/17.01.25 Stock

Warrant

DE000JL1MHY3

Market Closed - Börse Stuttgart 07:36:03 2024-05-27 EDT
0.6 EUR -16.67% Intraday chart for JP MORGAN/CALL/BECTON DICKINSON AND CO./280/0.1/17.01.25
Current month-31.43%
1 month-35.14%
Date Price Change
24-05-27 0.6 -16.67%
24-05-24 0.72 -18.18%
24-05-23 0.88 +3.53%
24-05-22 0.85 -9.57%
24-05-21 0.94 +3.30%

Delayed Quote Börse Stuttgart

Last update May 27, 2024 at 07:36 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JL1MHY
ISINDE000JL1MHY3
Date issued 2023-04-05
Strike 280 $
Maturity 2025-01-17 (235 Days)
Parity 10 : 1
Emission price 2.12
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.21
Lowest since issue 0.6
Spread 0.3
Spread %30.61%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
228.8 USD
Average target price
279 USD
Spread / Average Target
+21.95%
Consensus